Trouble viewing? Click here.


Maximize Your Business with the Right Partner

Although quality and innovation standards in Japan are comparable to that of the U.S. and European markets, the Japanese market can hold many regulatory and lingual obstacles for the first-timer.  As Japan's first CRO, CMIC is your most experienced partner in Japan.  Let our experts guide you in navigating the market.


Learn More >>

Coffee and conversation with
ANI Global Source at booth 121H63

When consistent supply for your patients is critical, you can rely on an ANI Global Source collaboration. ANI Global Source is a specialty CDMO supporting late stage development and commercial pharmaceutical manufacture of:

  • Oral dosage forms
  • Creams & Gels
  • Hormones
  • Potent compounds
  • Class II controlled substances

Manufacturing your product requires more than raw materials and established processes. At ANI Global Source, expertise, safety, reliability, and integrity are at the core of everything we produce. Visit us at booth 121H63 to learn more.

Integrated Sterile Injectable Contract Development & Manufacturing

Fully integrated CDMO for biologics bulk drug substance and sterile injectable drug products. Benefit from our turnkey upstream and downstream support for eukaryotic, microbial and viral expression as well as finished dose services.

  • Cell, Viral, and Microbial
  • Single-Use Platform (2L to 4000L Scale)
  • Process & Analytical Development
  • Parenteral Formulation Development
  • Fill/Finish Capabilities
    • Vials & Pre-Filled Syringes
    • Liquid & Lyophilized products

Read Our Latest Article


To learn more, visit us at CPhI WW, Stand 120A50 or contact us at [email protected]

BioVectra Inc. – Your North American CDMO Partner for Complex Synthetic Chemistry Challenges

We assists clients with small molecule cGMP projects from lab to multi-metric ton quantities. Our team provides phase appropriate route and process development solutions for short-term scale-up and long-term manufacturing challenges.


With vast experience in downstream purification techniques (chromatography, crystallization), we have completed 100+ chemical API projects (10 ongoing commercial products), including: complex multi-step synthesis, potent handling, and controlled substances. FDA & Health Canada inspected.


To meet our team at CPhI (booth 121H42), email [email protected]!

Connect with Baxter at CPhI Worldwide in Frankfurt

Formulation challenges. Clinical supply hurdles.  Lifecycle management. Risk mitigation. Patent expiry concerns. At BioPharma Solutions, a business unit of Baxter, we know the high-stakes challenges you face in today’s complex parenteral marketplace — and how the work we do is vital to the patients you serve.


If you have an injectable molecule and are looking for sterile contract manufacturing services, we invite you to stop by our stand at CPhI Worldwide in Frankfurt (Hall 12.1, Space F81) to meet with a representative and discuss how we can help you achieve your molecule’s full potential. Learn more.